| 前收市價 | 105.27 |
| 開市 | 105.98 |
| 買盤 | 0.00 x 1300 |
| 賣出價 | 0.00 x 800 |
| 今日波幅 | 105.38 - 107.77 |
| 52 週波幅 | 89.67 - 121.64 |
| 成交量 | |
| 平均成交量 | 5,939,977 |
| 市值 | 186.15B |
| Beta 值 (5 年，每月) | 0.74 |
| 市盈率 (最近 12 個月) | 33.42 |
| 每股盈利 (最近 12 個月) | 3.21 |
| 業績公佈日 | 2024年7月18日 - 2024年7月22日 |
| 遠期股息及收益率 | 2.20 (2.05%) |
| 除息日 | 2024年4月12日 |
| 1 年預測目標價 | 126.44 |
Insider MonkeyShould You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 2024 investor letter. A copy of the same can be downloaded here. The US stock market started 2024 optimistically. In the first quarter, the fund returned 8.29% (gross) and 8.09% (net) compared to 11.41% for the Russell 1000 Growth Index and […]
Insider MonkeyAbbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript April 17, 2024 Abbott Laboratories isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Robert Ford – Chairman and Chief Executive Officer: Phil Boudreau – Senior Vice President, Finance and Chief Financial Officer: Bob […]
Investor's Business DailyAbbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report
Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but Abbott stock slipped.
